Qi Ye
Interventional Pain Medicine · Houston, TXNPI 1447548961
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Boston Scientific at 25.1% of the total. Reporting peaked in 2021 at $795 and has fallen 97.9% since, to $17 in 2022. That places this record below the midpoint for interventional pain medicine clinicians in TX, where the typical reported total is $6,464.
Across 79 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$398
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$214
- Collegium Pharmaceutical, Inc.$194
- GRT US Holding, Inc.$124
- Medtronic$104
- Amgen$99
- plus $456 from 13 others
What the payments were for
- Travel & lodging$221%
- Food & beverage$1,56699%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $398 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $214 |
| Collegium Pharmaceutical, Inc. | 13 | $194 |
| GRT US Holding, Inc. | 9 | $124 |
| Medtronic | 1 | $104 |
| Amgen(2 entities) | 6 | $99 |
| AbbVie | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Scilex Pharmaceuticals Inc. | 3 | $47 |
| Abbott | 2 | $46 |
| Redhill Biopharma Inc. | 2 | $39 |
| Novartis | 2 | $35 |
| Electronic Waveform Lab, Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| Almatica Pharma LLC | 2 | $25 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Biodelivery Sciences International, Inc. | 2 | $25 |
| ERMI LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PAIN MANAGEMENT$227
- VECTRIS$104
How this compares
$1,588 in reported general payments places this provider in the 20th percentile of 287 interventional pain medicine providers in Texas.
Other interventional pain medicine in Houston
- Brian BruelHouston$219K
- Ioannis SkaribasHouston$92K
- George AtallahHouston$48K
- Shervin HarandiHouston$39K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Bolkar SahinlerLubbock$188K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.